OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells In Vitro and In Vivo
Carolini Kaid, Ernesto Goulart, Luiz C. Caires-Júnior, et al.
Cancer Research (2018) Vol. 78, Iss. 12, pp. 3363-3374
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Emerging therapies for glioblastoma: current state and future directions
Rong Liang, Ni Li, Zhenzhen Zhang
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 308

Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis
Zhe Zhu, Pinar Mesci, Jean Bernatchez, et al.
Cell stem cell (2020) Vol. 26, Iss. 2, pp. 187-204.e10
Open Access | Times Cited: 156

Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Atheer Khdyair Hamad, Gaukhar M. Yusubalieva, Владимир П. Баклаушев, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 547-547
Open Access | Times Cited: 59

Delivery and Biosafety of Oncolytic Virotherapy
Lizhi Li, Shixin Liu, Duoduo Han, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 132

Flaviviridae Viruses and Oxidative Stress: Implications for Viral Pathogenesis
Zhenzhen Zhang, Rong Liang, Yi‐Ping Li
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-17
Open Access | Times Cited: 81

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Jiayi Zeng, Xiangxue Li, Max Sander, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 64

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
Jonathan Pol, Sarah Lévesque, Samuel T. Workenhe, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1503032-e1503032
Open Access | Times Cited: 75

Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
Sharmila Nair, Luciano Mazzoccoli, Arijita Jash, et al.
JCI Insight (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 69

Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma
Lishu Chen, Chao Zhou, Qi Chen, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 522-534
Open Access | Times Cited: 32

Modeling glioblastoma complexity with organoids for personalized treatments
Kristen D. Pawlowski, Joseph Duffy, Maria V. Babak, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 282-296
Open Access | Times Cited: 17

Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors
Gabriela Machado Novaes, Caroline Lima, Carla Longo, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 440-456
Open Access | Times Cited: 7

Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors
Carolini Kaid, Raquel Azevedo dos Santos Madi, Renato Mancini Astray, et al.
Molecular Therapy (2020) Vol. 28, Iss. 5, pp. 1276-1286
Open Access | Times Cited: 40

The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner
Joseph Mazar, Jeanne K. Brooks, Matthew Peloquin, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 1, pp. 65-80
Open Access | Times Cited: 5

Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies
Niloofar Kiaheyrati, Abouzar Babaei, Reza Ranji, et al.
Life Sciences (2024) Vol. 349, pp. 122734-122734
Closed Access | Times Cited: 5

Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24
Joseph Mazar, Yujia Li, Amy Rosado, et al.
PLoS ONE (2018) Vol. 13, Iss. 7, pp. e0200358-e0200358
Open Access | Times Cited: 40

IL-1 receptor antagonist therapy mitigates placental dysfunction and perinatal injury following Zika virus infection
Jun Lei, Meghan S. Vermillion, Bei Jia, et al.
JCI Insight (2019) Vol. 4, Iss. 7
Open Access | Times Cited: 37

Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells
Ivan Trus, Nathalie G. Bérubé, Peng Jiang, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 579-579
Open Access | Times Cited: 33

Zika virus cleaves GSDMD to disseminate prognosticable and controllable oncolysis in a human glioblastoma cell model
Yu-Ting Kao, Hsin-I Wang, Chi-Ting Shie, et al.
Molecular Therapy — Oncolytics (2023) Vol. 28, pp. 104-117
Open Access | Times Cited: 12

Oncolytic Virus‐Driven Biotherapies from Bench to Bedside
Shijie Duan, Shuhang Wang, Lei Qiao, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 12

Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells
Carla Bianca Luena Victorio, Wisna Novera, Arun Ganasarajah, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma
Samantha Epistolio, Paolo Spina, Ismail Zaed, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2723-2723
Open Access

AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines
Samuel D. Zwernik, Beau H. Adams, Daniel A. Raymond, et al.
Molecular Therapy — Oncolytics (2021) Vol. 23, pp. 447-457
Open Access | Times Cited: 26

Page 1 - Next Page

Scroll to top